According to a Reuters story, German drug manufacturer Bayer is seeking European approval of a contraceptive skin patch.
The story notes that Bayer’s main oral contraceptive brand, Yasmin, has generated controversy over health risks. The company has so far agreed to pay a combined $400 million to settle almost one third of about 6,000 legal claims in the U.S. that Yasmin caused ...
continue reading...